Global Lung Disease Therapeutic Supply, Demand and Key Producers, 2023-2029

March 2023 | 114 pages | ID: G7C19C4D9664EN
GlobalInfoResearch

Abstracts

The global Lung Disease Therapeutic market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Lung Disease Therapeutic demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Lung Disease Therapeutic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Lung Disease Therapeutic that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Lung Disease Therapeutic total market, 2018-2029, (USD Million)

Global Lung Disease Therapeutic total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Lung Disease Therapeutic total market, key domestic companies and share, (USD Million)

Global Lung Disease Therapeutic revenue by player and market share 2018-2023, (USD Million)

Global Lung Disease Therapeutic total market by Type, CAGR, 2018-2029, (USD Million)

Global Lung Disease Therapeutic total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Lung Disease Therapeutic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, AstraZeneca, Boehringer Ingelheim, Novartis, Mylan, Vertex Pharmaceuticals, F. Hoffman La Roche, Teva Pharmaceuticals and Cipla, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Lung Disease Therapeutic market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Lung Disease Therapeutic Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Lung Disease Therapeutic Market, Segmentation by Type

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Lung Cancer
• Other

Global Lung Disease Therapeutic Market, Segmentation by Application

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Companies Profiled:

• GSK
• AstraZeneca
• Boehringer Ingelheim
• Novartis
• Mylan
• Vertex Pharmaceuticals
• F. Hoffman La Roche
• Teva Pharmaceuticals
• Cipla
• Fibrogen
• Liminal Biosciences
• PharmAkea Therapeutics
• IQVIA

Key Questions Answered

1. How big is the global Lung Disease Therapeutic market?

2. What is the demand of the global Lung Disease Therapeutic market?

3. What is the year over year growth of the global Lung Disease Therapeutic market?

4. What is the total value of the global Lung Disease Therapeutic market?

5. Who are the major players in the global Lung Disease Therapeutic market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Lung Disease Therapeutic Introduction
1.2 World Lung Disease Therapeutic Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Lung Disease Therapeutic Total Market by Region (by Headquarter Location)
  1.3.1 World Lung Disease Therapeutic Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Lung Disease Therapeutic Market Size (2018-2029)
  1.3.3 China Lung Disease Therapeutic Market Size (2018-2029)
  1.3.4 Europe Lung Disease Therapeutic Market Size (2018-2029)
  1.3.5 Japan Lung Disease Therapeutic Market Size (2018-2029)
  1.3.6 South Korea Lung Disease Therapeutic Market Size (2018-2029)
  1.3.7 ASEAN Lung Disease Therapeutic Market Size (2018-2029)
  1.3.8 India Lung Disease Therapeutic Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Lung Disease Therapeutic Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Lung Disease Therapeutic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Lung Disease Therapeutic Consumption Value (2018-2029)
2.2 World Lung Disease Therapeutic Consumption Value by Region
  2.2.1 World Lung Disease Therapeutic Consumption Value by Region (2018-2023)
  2.2.2 World Lung Disease Therapeutic Consumption Value Forecast by Region (2024-2029)
2.3 United States Lung Disease Therapeutic Consumption Value (2018-2029)
2.4 China Lung Disease Therapeutic Consumption Value (2018-2029)
2.5 Europe Lung Disease Therapeutic Consumption Value (2018-2029)
2.6 Japan Lung Disease Therapeutic Consumption Value (2018-2029)
2.7 South Korea Lung Disease Therapeutic Consumption Value (2018-2029)
2.8 ASEAN Lung Disease Therapeutic Consumption Value (2018-2029)
2.9 India Lung Disease Therapeutic Consumption Value (2018-2029)

3 WORLD LUNG DISEASE THERAPEUTIC COMPANIES COMPETITIVE ANALYSIS

3.1 World Lung Disease Therapeutic Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Lung Disease Therapeutic Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Lung Disease Therapeutic in 2022
  3.2.3 Global Concentration Ratios (CR8) for Lung Disease Therapeutic in 2022
3.3 Lung Disease Therapeutic Company Evaluation Quadrant
3.4 Lung Disease Therapeutic Market: Overall Company Footprint Analysis
  3.4.1 Lung Disease Therapeutic Market: Region Footprint
  3.4.2 Lung Disease Therapeutic Market: Company Product Type Footprint
  3.4.3 Lung Disease Therapeutic Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Lung Disease Therapeutic Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Lung Disease Therapeutic Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Lung Disease Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Lung Disease Therapeutic Consumption Value Comparison
  4.2.1 United States VS China: Lung Disease Therapeutic Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Lung Disease Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Lung Disease Therapeutic Companies and Market Share, 2018-2023
  4.3.1 United States Based Lung Disease Therapeutic Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Lung Disease Therapeutic Revenue, (2018-2023)
4.4 China Based Companies Lung Disease Therapeutic Revenue and Market Share, 2018-2023
  4.4.1 China Based Lung Disease Therapeutic Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Lung Disease Therapeutic Revenue, (2018-2023)
4.5 Rest of World Based Lung Disease Therapeutic Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Lung Disease Therapeutic Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Lung Disease Therapeutic Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Lung Disease Therapeutic Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Asthma
  5.2.2 Chronic Obstructive Pulmonary Disease (COPD)
  5.2.3 Lung Cancer
  5.2.4 Other
5.3 Market Segment by Type
  5.3.1 World Lung Disease Therapeutic Market Size by Type (2018-2023)
  5.3.2 World Lung Disease Therapeutic Market Size by Type (2024-2029)
  5.3.3 World Lung Disease Therapeutic Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Lung Disease Therapeutic Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital Pharmacies
  6.2.2 Retail Pharmacies
  6.2.3 Online Pharmacies
6.3 Market Segment by Application
  6.3.1 World Lung Disease Therapeutic Market Size by Application (2018-2023)
  6.3.2 World Lung Disease Therapeutic Market Size by Application (2024-2029)
  6.3.3 World Lung Disease Therapeutic Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 GSK
  7.1.1 GSK Details
  7.1.2 GSK Major Business
  7.1.3 GSK Lung Disease Therapeutic Product and Services
  7.1.4 GSK Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 GSK Recent Developments/Updates
  7.1.6 GSK Competitive Strengths & Weaknesses
7.2 AstraZeneca
  7.2.1 AstraZeneca Details
  7.2.2 AstraZeneca Major Business
  7.2.3 AstraZeneca Lung Disease Therapeutic Product and Services
  7.2.4 AstraZeneca Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 AstraZeneca Recent Developments/Updates
  7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Boehringer Ingelheim
  7.3.1 Boehringer Ingelheim Details
  7.3.2 Boehringer Ingelheim Major Business
  7.3.3 Boehringer Ingelheim Lung Disease Therapeutic Product and Services
  7.3.4 Boehringer Ingelheim Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Boehringer Ingelheim Recent Developments/Updates
  7.3.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.4 Novartis
  7.4.1 Novartis Details
  7.4.2 Novartis Major Business
  7.4.3 Novartis Lung Disease Therapeutic Product and Services
  7.4.4 Novartis Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Novartis Recent Developments/Updates
  7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Mylan
  7.5.1 Mylan Details
  7.5.2 Mylan Major Business
  7.5.3 Mylan Lung Disease Therapeutic Product and Services
  7.5.4 Mylan Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Mylan Recent Developments/Updates
  7.5.6 Mylan Competitive Strengths & Weaknesses
7.6 Vertex Pharmaceuticals
  7.6.1 Vertex Pharmaceuticals Details
  7.6.2 Vertex Pharmaceuticals Major Business
  7.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Product and Services
  7.6.4 Vertex Pharmaceuticals Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Vertex Pharmaceuticals Recent Developments/Updates
  7.6.6 Vertex Pharmaceuticals Competitive Strengths & Weaknesses
7.7 F. Hoffman La Roche
  7.7.1 F. Hoffman La Roche Details
  7.7.2 F. Hoffman La Roche Major Business
  7.7.3 F. Hoffman La Roche Lung Disease Therapeutic Product and Services
  7.7.4 F. Hoffman La Roche Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 F. Hoffman La Roche Recent Developments/Updates
  7.7.6 F. Hoffman La Roche Competitive Strengths & Weaknesses
7.8 Teva Pharmaceuticals
  7.8.1 Teva Pharmaceuticals Details
  7.8.2 Teva Pharmaceuticals Major Business
  7.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Product and Services
  7.8.4 Teva Pharmaceuticals Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Teva Pharmaceuticals Recent Developments/Updates
  7.8.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.9 Cipla
  7.9.1 Cipla Details
  7.9.2 Cipla Major Business
  7.9.3 Cipla Lung Disease Therapeutic Product and Services
  7.9.4 Cipla Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Cipla Recent Developments/Updates
  7.9.6 Cipla Competitive Strengths & Weaknesses
7.10 Fibrogen
  7.10.1 Fibrogen Details
  7.10.2 Fibrogen Major Business
  7.10.3 Fibrogen Lung Disease Therapeutic Product and Services
  7.10.4 Fibrogen Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Fibrogen Recent Developments/Updates
  7.10.6 Fibrogen Competitive Strengths & Weaknesses
7.11 Liminal Biosciences
  7.11.1 Liminal Biosciences Details
  7.11.2 Liminal Biosciences Major Business
  7.11.3 Liminal Biosciences Lung Disease Therapeutic Product and Services
  7.11.4 Liminal Biosciences Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Liminal Biosciences Recent Developments/Updates
  7.11.6 Liminal Biosciences Competitive Strengths & Weaknesses
7.12 PharmAkea Therapeutics
  7.12.1 PharmAkea Therapeutics Details
  7.12.2 PharmAkea Therapeutics Major Business
  7.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Product and Services
  7.12.4 PharmAkea Therapeutics Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 PharmAkea Therapeutics Recent Developments/Updates
  7.12.6 PharmAkea Therapeutics Competitive Strengths & Weaknesses
7.13 IQVIA
  7.13.1 IQVIA Details
  7.13.2 IQVIA Major Business
  7.13.3 IQVIA Lung Disease Therapeutic Product and Services
  7.13.4 IQVIA Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 IQVIA Recent Developments/Updates
  7.13.6 IQVIA Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Lung Disease Therapeutic Industry Chain
8.2 Lung Disease Therapeutic Upstream Analysis
8.3 Lung Disease Therapeutic Midstream Analysis
8.4 Lung Disease Therapeutic Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Lung Disease Therapeutic Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Lung Disease Therapeutic Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Lung Disease Therapeutic Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Lung Disease Therapeutic Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Lung Disease Therapeutic Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Lung Disease Therapeutic Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Lung Disease Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Lung Disease Therapeutic Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Lung Disease Therapeutic Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Lung Disease Therapeutic Players in 2022
Table 12. World Lung Disease Therapeutic Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Lung Disease Therapeutic Company Evaluation Quadrant
Table 14. Head Office of Key Lung Disease Therapeutic Player
Table 15. Lung Disease Therapeutic Market: Company Product Type Footprint
Table 16. Lung Disease Therapeutic Market: Company Product Application Footprint
Table 17. Lung Disease Therapeutic Mergers & Acquisitions Activity
Table 18. United States VS China Lung Disease Therapeutic Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Lung Disease Therapeutic Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Lung Disease Therapeutic Companies, Headquarters (States, Country)
Table 21. United States Based Companies Lung Disease Therapeutic Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Lung Disease Therapeutic Revenue Market Share (2018-2023)
Table 23. China Based Lung Disease Therapeutic Companies, Headquarters (Province, Country)
Table 24. China Based Companies Lung Disease Therapeutic Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Lung Disease Therapeutic Revenue Market Share (2018-2023)
Table 26. Rest of World Based Lung Disease Therapeutic Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Lung Disease Therapeutic Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Lung Disease Therapeutic Revenue Market Share (2018-2023)
Table 29. World Lung Disease Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Lung Disease Therapeutic Market Size by Type (2018-2023) & (USD Million)
Table 31. World Lung Disease Therapeutic Market Size by Type (2024-2029) & (USD Million)
Table 32. World Lung Disease Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Lung Disease Therapeutic Market Size by Application (2018-2023) & (USD Million)
Table 34. World Lung Disease Therapeutic Market Size by Application (2024-2029) & (USD Million)
Table 35. GSK Basic Information, Area Served and Competitors
Table 36. GSK Major Business
Table 37. GSK Lung Disease Therapeutic Product and Services
Table 38. GSK Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. GSK Recent Developments/Updates
Table 40. GSK Competitive Strengths & Weaknesses
Table 41. AstraZeneca Basic Information, Area Served and Competitors
Table 42. AstraZeneca Major Business
Table 43. AstraZeneca Lung Disease Therapeutic Product and Services
Table 44. AstraZeneca Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. AstraZeneca Recent Developments/Updates
Table 46. AstraZeneca Competitive Strengths & Weaknesses
Table 47. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 48. Boehringer Ingelheim Major Business
Table 49. Boehringer Ingelheim Lung Disease Therapeutic Product and Services
Table 50. Boehringer Ingelheim Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Boehringer Ingelheim Recent Developments/Updates
Table 52. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 53. Novartis Basic Information, Area Served and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Lung Disease Therapeutic Product and Services
Table 56. Novartis Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novartis Recent Developments/Updates
Table 58. Novartis Competitive Strengths & Weaknesses
Table 59. Mylan Basic Information, Area Served and Competitors
Table 60. Mylan Major Business
Table 61. Mylan Lung Disease Therapeutic Product and Services
Table 62. Mylan Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Mylan Recent Developments/Updates
Table 64. Mylan Competitive Strengths & Weaknesses
Table 65. Vertex Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. Vertex Pharmaceuticals Major Business
Table 67. Vertex Pharmaceuticals Lung Disease Therapeutic Product and Services
Table 68. Vertex Pharmaceuticals Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Vertex Pharmaceuticals Recent Developments/Updates
Table 70. Vertex Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. F. Hoffman La Roche Basic Information, Area Served and Competitors
Table 72. F. Hoffman La Roche Major Business
Table 73. F. Hoffman La Roche Lung Disease Therapeutic Product and Services
Table 74. F. Hoffman La Roche Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. F. Hoffman La Roche Recent Developments/Updates
Table 76. F. Hoffman La Roche Competitive Strengths & Weaknesses
Table 77. Teva Pharmaceuticals Basic Information, Area Served and Competitors
Table 78. Teva Pharmaceuticals Major Business
Table 79. Teva Pharmaceuticals Lung Disease Therapeutic Product and Services
Table 80. Teva Pharmaceuticals Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Teva Pharmaceuticals Recent Developments/Updates
Table 82. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 83. Cipla Basic Information, Area Served and Competitors
Table 84. Cipla Major Business
Table 85. Cipla Lung Disease Therapeutic Product and Services
Table 86. Cipla Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Cipla Recent Developments/Updates
Table 88. Cipla Competitive Strengths & Weaknesses
Table 89. Fibrogen Basic Information, Area Served and Competitors
Table 90. Fibrogen Major Business
Table 91. Fibrogen Lung Disease Therapeutic Product and Services
Table 92. Fibrogen Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Fibrogen Recent Developments/Updates
Table 94. Fibrogen Competitive Strengths & Weaknesses
Table 95. Liminal Biosciences Basic Information, Area Served and Competitors
Table 96. Liminal Biosciences Major Business
Table 97. Liminal Biosciences Lung Disease Therapeutic Product and Services
Table 98. Liminal Biosciences Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Liminal Biosciences Recent Developments/Updates
Table 100. Liminal Biosciences Competitive Strengths & Weaknesses
Table 101. PharmAkea Therapeutics Basic Information, Area Served and Competitors
Table 102. PharmAkea Therapeutics Major Business
Table 103. PharmAkea Therapeutics Lung Disease Therapeutic Product and Services
Table 104. PharmAkea Therapeutics Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. PharmAkea Therapeutics Recent Developments/Updates
Table 106. IQVIA Basic Information, Area Served and Competitors
Table 107. IQVIA Major Business
Table 108. IQVIA Lung Disease Therapeutic Product and Services
Table 109. IQVIA Lung Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of Lung Disease Therapeutic Upstream (Raw Materials)
Table 111. Lung Disease Therapeutic Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Lung Disease Therapeutic Picture
Figure 2. World Lung Disease Therapeutic Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Lung Disease Therapeutic Total Market Size (2018-2029) & (USD Million)
Figure 4. World Lung Disease Therapeutic Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Lung Disease Therapeutic Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Lung Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Lung Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Lung Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Lung Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Lung Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Lung Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Lung Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 13. Lung Disease Therapeutic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Lung Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 16. World Lung Disease Therapeutic Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Lung Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 18. China Lung Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Lung Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Lung Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Lung Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Lung Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 23. India Lung Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Lung Disease Therapeutic by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Lung Disease Therapeutic Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Lung Disease Therapeutic Markets in 2022
Figure 27. United States VS China: Lung Disease Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Lung Disease Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Lung Disease Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Lung Disease Therapeutic Market Size Market Share by Type in 2022
Figure 31. Asthma
Figure 32. Chronic Obstructive Pulmonary Disease (COPD)
Figure 33. Lung Cancer
Figure 34. Other
Figure 35. World Lung Disease Therapeutic Market Size Market Share by Type (2018-2029)
Figure 36. World Lung Disease Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Lung Disease Therapeutic Market Size Market Share by Application in 2022
Figure 38. Hospital Pharmacies
Figure 39. Retail Pharmacies
Figure 40. Online Pharmacies
Figure 41. Lung Disease Therapeutic Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source